Karin Shanahan

Top questions we hope to answer- How do you get on a board? Does being on a non-profit board help? Where and when to start?

31

3 Comments

I love this work led by US Pharmacopeia Council of Experts member Jane Weitzel. Supporting systems than ensure the quality of medicines is clearly in the interest of patient and public health on its face but, if you consider the application of this work across 22,000 drug manufacturing sites around the world, the impact on planet health is also clear. And, another bonus …. using fewer natural resources also reduces costs and saves money. Win for patients, win for the planet, and a win for industry! A trifecta of impact.

46

Providing feedback in the right way can enhance training and employee growth/engagement, which is why it is an important skill to practice.

35

2 Comments

📣 Over the years, I have discovered what truly makes a difference as a leader. It's good to focus on technical excellence and scientific innovation, but what truly motivates teams is our ability to cultivate human qualities that allow us to connect, understand, and inspire others. 💡 According to a recent Forbes article, soft skills are now essential to modern leadership. And I couldn't agree more. Empathy, flexibility, and creativity are essential skills that shape how we work together and tackle challenges. I have seen our teams overcome challenges through clear communication and mutual support. Most importantly, I have witnessed the profound impact of a leader who truly listens and adapts to the needs of their team.  As a team, we can create an environment where everyone feels valued and inspired to give their best. Read this article 👉https://lnkd.in/eKePuTUi  #Leadership #Human #SoftSkills #Innovation #Empathy #Creativity

51

1 Comment

Anyone who knows me knows that my commitment to diversity, equity and inclusion in science runs deep. I have seen through my own experience that prioritizing equity and representation within an organization is not just a moral imperative, but also a strategic asset. And as a business leader, people manager and scientific head, I’m proud of what I’ve seen in Sanofi's Diversity, Equity & Inclusion Report for 2023. 44% of our senior leaders are women. 100% of our clinical trials in the US have diversity targets. And the gender pay gap is less than 5% in most of our countries. To be clear, we aren’t there yet against all of our 2025 Global DE&I ambitions. Even when we do reach the numbers we’ve set for ourselves, we’ll still have improvements to make. But our commitment is real, and so is the progress. This progress is especially critical – and I would argue maybe more than anywhere else – in R&D. Clinical research requires embracing the diversity of perspectives, backgrounds and experiences that reflect the patients we are serving. Game-changing medicine doesn’t come from a single group of like minds. If everyone in the room looks and sounds the same, I know from experience that we aren’t going to succeed. I believe Sanofi can be a force for positive change in the world, and I plan to make R&D an example. Read more about all of the incredible work my colleagues across Sanofi are already doing here: https://lnkd.in/efar2sQU #DiversityEquityInclusion #AllIn #SanofiDEIReport2023

532

8 Comments

This blog explores living with purpose, embracing risk, and making a meaningful impact. It highlights how focusing on gratitude, growth, and inspiring others can ignite your "torch" and light the way forward.

12

1 Comment

As a husband and father, I want the women in my life to feel supported, heard and validated so I am excited to be a part of team Midol, whose mission is to end the normalization of discomfort. Today, Midol is continuing their Comfort is Power platform with the new PeriodTalk initiative, underscoring real world insights from our consumers and advocating for continued dialogue around how periods are experienced.   Our program survey, conducted with partner PERIOD., demonstrated; half of respondents did not know what was happening to their body when they first experienced menstrual symptoms. Moreso, 85% of respondents reported their period symptoms have impacted their daily lives within the past 3 months. Additionally, over 40% of respondents said they could not fully engage in school or work in the past year due to period symptoms.   There are few other parallels when considering how we manage pain and discomfort as a society, and we want to empower all those who require relief to be able to find it.   After kicking off this important conversation, we look forward to seeing what our partners, Charis Chambers, MD and Victoria Garrick Browne, and their networks will add to our PeriodTalk. I encourage anyone else who is interested in our work as a menstrual health brand to follow us at Midol.com or on our social channels (@midol on IG and TikTok). #PeriodEducation #WomensHealth #Pain #Marketing #TeamBayer Thanks to an amazing team of leaders: Lauren Carmody, Andrea Fischer, Emely Deleon, David Gibbons, Melissa Harris, Karen Alfieri Hefner, Sistine Jarvis, Esther Mezhibovsky, Cassidy Cardone, Kana Schmidt, twelvenote agency, OLIVER Agency, Sasha Media Agency

131

7 Comments

Failure can be a heavy word. How do we learn and grow from it? Here are some suggestions in this week's post on songs and strategy. #changemanagement #strategy #executivecoaching #values #failforward #managementconsulting

3

Last week, I joined a dynamic conversation hosted by The Chamber of Commerce for Greater Philadelphia about the region’s thriving life sciences industry. Moderated by Life Sciences Pennsylvania, the discussion focused on how Johnson & Johnson and other companies contribute to and benefit from the region’s innovation and economic development. In addition, I shared how Johnson & Johnson has leveraged the scientific and medical ecosystem in PA to bring the best solutions, products, and services to patients, including:   ·     Globally, we have invested $77B in research and development since 2016 and our North America research and development site is located in suburban Philadelphia. ·     We focus on cell and gene therapies that create personalized solutions for patients and build strategic partnerships to scale the development of complex products. ·     We are an inclusive company that recruits and nurtures talent, providing access to future-forward technology knowledge and skill-building within life sciences and healthcare i.e. artificial intelligence.   There has been significant and ambitious innovation especially over the past 20 years. The Philadelphia region has made exciting contributions to this trend. Where are we going in the next 20 years? I'm excited and hopeful.

107

1 Comment

A nice short HBR read as we are trying to modernize our ways of working, drive thoughtful risk taking and empower our talents for more innovation, more value creation — Many thanks Jasmine Chang for sharing !

53

2 Comments

🚨 Biosimilar Shake-Up: The Adalimumab Landscape is Evolving Fast Ten biosimilars of Humira (adalimumab) hit the market since 2023, but recent strategies are rewriting the playbook. What's driving this shift? Check out our latest blog from my colleagues Aanam Aslam Mahmood, MPH and Ruthy Glass, PhD where they break down the impact of co-promotions, formulary changes, and the strategies that are reshaping the market. 📈 👉Don't miss out on these early insights:

24

My favorite days at work are those when I get to connect with patients – to hear their stories, witness their resilience, and on the best days, learn how one of our therapies is helping them. I’m constantly inspired by the courage of people living with Crohn’s disease and ulcerative colitis – and the families who support them. Invisible but powerful, these autoimmune diseases impact every part of daily life. That’s why my team at Johnson & Johnson Innovative Medicine is committed to helping more patients achieve remission.       This Crohn’s & Colitis Awareness Week, learn more about inflammatory bowel disease: https://bit.ly/3VkrUt7 #JNJImmunology #MyCompany 

80

2 Comments

Situationships: What They Are and 5 Signs You’re in One : “Situationship” isn’t a word you’ll find in the dictionary, but it’s hard to avoid in popular culture. So, what is it exactly? According to psychologist Dr. Susan Albers, a situationship is a romantic relationship that hasn’t been formalized. “Situationships are characterized by a lack of obligation or exclusivity, but the real hallmark is a lack of clear boundaries or labels,” she explains. “There are elements of friendship and romance, but they exist without defining the relationship. So, essentially, you have many of the benefits of a traditional relationship without having to make a commitment.” As you can imagine, this kind of attachment has upsides and downsides. One the one hand, situationships may allow you to feel the sense of connection you’d experience in a standard-issue relationship and the independence that comes with being single. On the other hand, if you’re not clear on the nature of your involvement, it can’t progress. It’s difficult to maintain, emotionally. For further reading :

1

Love moves the world. When death halts, chaos ensues; love transforms death herself, revealing humanity's need for compassion, mortality, and purpose. A great book (my friend during my last trip to Zurich) from one of my favorites writers such José Saramago. The book is "Le Intermittenze della Morte" (Death with Interruptions in English). The book parallels leadership by highlighting the importance of embracing impermanence and adapting to change. Death's vulnerability and choice to act out of love symbolize authentic leadership—balancing authority with empathy. The value of love transcends control, showing that compassion and connection are vital in guiding others and confronting life's inevitabilities.

53

2 Comments

Regulatory Update with Office of Pharmaceutical Quality (OPQ) Reorganization, #CDER, FDA, over 5,000 manufacturing facilities worldwide, providing guidance and quality assurance, pharmaceutical quality, regulatory decision. FDA is announcing a webinar on the reorganization of the Center for Drug Evaluation and Research’s (#CDER) Office of Pharmaceutical Quality (#OPQ). This reorganization was implemented in January and does not result in any direct or immediate changes for external groups, including drug manufacturers. This reorganization enables OPQ to evolve and adapt to the ever-changing global healthcare landscape and: - Streamline processes and systems for enhanced efficiency, eliminating operational redundancies and bottlenecks. - Embrace new technologies and tools as the key to staying ahead in a dynamic environment. - Actively pursue innovation to make a meaningful difference in patients' lives. Adopt a culture of continuous improvement, in which OPQ is consistently seeking better and more efficient ways of working and advancing the field. OPQ restructured to increase the ability to respond to changes in workload, increasing complexity of pharmaceutical supply chains, and public health emergencies. OPQ created five new offices to allow quick response to demands and public health needs and allow for an integrated quality assessment of products throughout their lifecycle. This webinar describes the new structure of OPQ and how it continues to advance the quality of drugs. https://lnkd.in/esNHMDTG

7

My 11th book was just published! Thanks all for support and help. Below is the link for this book. https://lnkd.in/e357xSHq

35

8 Comments

“I wonder… 🙄 🛏 Why does it take so long to talk about medications? These are not bedtime stories." 📚 Well, in real life, the time it takes to understand medication instructions is never very long. If you have any questions about your medicine, always ask your pharmacist. Teva cares about you and how you use your medicines. 💚 You can read more about our campaign at: https://lnkd.in/dQAkYMUX #TevaPharmaceuticalsPolska #TevaOperationsPoland #SUOM #TevaPharmaceuticalsPolska #TevaOperationsPoland #SUOM

2

1 Comment